Evidence map›Paper›PMID 40272929›Full record

ArticleThe Journal of infectious diseases2025

Development of a Procedure for Prion Surveillance in the Laboratory Setting.

Damian Gorski, Isaac Schauer, Kane Spicker, Ananya Tupaki-Sreepurna, Fei Wang, Claudio Soto, Sandra Pritzkow

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Damian GorskiDepartment of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School at Houston, Houston, Texas, USA.ORCID 0000-0001-6951-1456
Isaac SchauerDepartment of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School at Houston, Houston, Texas, USA.
Kane SpickerDepartment of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School at Houston, Houston, Texas, USA.
Ananya Tupaki-SreepurnaDepartment of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School at Houston, Houston, Texas, USA.ORCID 0000-0001-6665-1488
Fei WangDepartment of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School at Houston, Houston, Texas, USA.ORCID 0000-0003-1798-0829
Claudio SotoDepartment of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School at Houston, Houston, Texas, USA.
Sandra PritzkowDepartment of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School at Houston, Houston, Texas, USA.ORCID 0000-0001-5550-5573

Funding

Zoonotic potential of CWD and influence of environmental contamination on prion propagationP01AI077774 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Glenn C Telling · 2008 to 2026
$36.1M
NIAID NIH HHS P01 AI077774NIH HHS P01AI077774
6 · The paper itself

Abstract

Infectious prions readily adhere to common surfaces, retain infectivity, and are highly resistant to conventional decontamination, posing significant biosafety challenges in the medical and research environments. Recent occupational exposures underscore the urgency of improving safety measures. Here, we describe an approach combining foam-swab surface sampling and protein misfolding cyclic amplification to enhance prion surveillance. Our results demonstrate the ability to detect prions most relevant to human health directly from contaminated surfaces, even at 100 million-fold dilutions of the brain. We applied our method to assess the completeness of prion decontamination and show that high prion quantities can resist even approved inactivation methods. Finally, we applied our method in 2 real-world scenarios including the decommissioning and repurposing of a prion research facility and the active surveillance of residual prion contamination in an operational laboratory. Our methodology offers a robust and efficient tool for detecting residual prion contamination, enhancing laboratory safety.

Indexed as

DecontaminationPrion DiseasesPrionsAnimalsContainment of BiohazardsHumansLaboratoriesPrionsCJDCreutzfeldt-Jakob diseaselaboratory safetyPMCAprions

Identifiers

PMID40272929
PMCPMC12718057

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.